Skip to content

Press Releases

Year : 2018
Date Title
13/11/2018 Illumina to Webcast Upcoming Investor Conference Presentations
01/11/2018 Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion, Broadening Access to Long-Read Sequencing and Accelerating Scientific Discovery
30/10/2018 Illumina Launches TruSight Oncology 500 to Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling
23/10/2018 Illumina Reports Financial Results for Third Quarter of Fiscal Year 2018
09/10/2018 Illumina to Announce Third Quarter 2018 Financial Results on Tuesday, October 23, 2018
28/09/2018 Illumina Announces Conversion Period for 0% Convertible Senior Notes due 2019 and 0.5% Convertible Senior Notes due 2021
30/08/2018 Illumina to Webcast Upcoming Investor Conference Presentation
27/08/2018 Illumina Receives Approval of MiSeq™Dx System in China
16/08/2018 Illumina Announces Pricing of Convertible Senior Notes
15/08/2018 Illumina to Offer $650 Million Convertible Senior Notes
30/07/2018 Illumina Reports Financial Results for Second Quarter of Fiscal Year 2018
10/07/2018 Illumina to Announce Second Quarter 2018 Financial Results on Monday, July 30, 2018
29/05/2018 Illumina to Webcast Upcoming Investor Conference Presentations
15/05/2018 Illumina Acquires Edico Genome to Accelerate Genomic Data Analysis
02/05/2018 Illumina to Webcast Upcoming Investor Conference Presentation
24/04/2018 Illumina Reports Financial Results for First Quarter of Fiscal Year 2018
13/04/2018 Bristol-Myers Squibb and Illumina Announce Strategic Collaboration to Develop and Commercialize Companion Diagnostics for Bristol-Myers Squibb’s Oncology Immunotherapies
10/04/2018 Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics
10/04/2018 Illumina to Announce First Quarter 2018 Financial Results on Tuesday, April 24, 2018
12/03/2018 Illumina Names Dr. Phil Febbo Chief Medical Officer
27/02/2018 Illumina to Webcast Upcoming Investor Conference Presentation
30/01/2018 Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2017
26/01/2018 Illumina Awarded $26.7M in Patent Suit Against Ariosa Diagnostics, Inc.
16/01/2018 Illumina to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, January 30, 2018
08/01/2018 Thermo Fisher Scientific and Illumina Sign Agreement to Provide Research Market Broader Access to Ion AmpliSeq Technology
08/01/2018 Illumina Launches iSeq 100 Sequencing System
04/01/2018 Illumina and KingMed Diagnostics Partner to Develop Next-Generation Sequencing Technology for Chinese FDA Approval